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NORSK SAMMENDRAG
Det er kjent at lav konsentrasjon av serumalbumin er en risikofaktor for hjerte- og karsykdommer. I
Helseundersøkelsen i Oslo inngår blant annet spørsmål om hjerteinfarkt. Konsentrasjonen av
serumalbumin ble målt på 5224 individer. Verdiene er nær normalfordelt hos begge kjønn, med en
forskyvning mot noe lavere verdier hos kvinner. For menn er det fallende albuminverdier med økende
alder. Hos kvinner er det liten forskjell i albuminverdien i de to laveste aldersgruppene (30 og 40+45-
åringene), men deretter fallende verdier. Lav albumin (≤47 g/l) vs høy (>47 g/l) er assosiert med økt
prevalens av (selvrapportert) hjerteinfarkt (Odds Ratio=1,95; 95% CI=1,30–2,93; p=0,001), angina
pectoris (OR=1,44; 95% CI=1,04–2,01; p=0,03) og brystsmerter ved å gå i trapper/bakker (OR=1,36;
95% CI=1,12–1,64; p=0,002), etter justering for alder, kjønn og røyking. Albumin er en viktig ekstra-
cellulær antioksidant. Peroksidering av lipider (bl.a. av LDL) kan øke risikoen for koronar hjertesyk-
dom. I materialet ble det funnet positiv sammenheng mellom alder (og LDL) og serum TBARS, som er
et mål på lipidperoksidering. Hos menn var det invers sammenheng mellom albumin og TBARS. Lave
TBARS-verdier var assosiert med redusert ’risiko’ for å rapportere angina pectoris (OR=0,80; 95%
CI=0,688–0,933; p=0,004), noe som reiser spørsmålet om den antatt beskyttende effekten av serum-
albumin mot koronarsykdom delvis kunne bero på beskyttelse mot lipidperoksider. Det forhold at
albuminverdien hos kvinner ikke faller før etter menopausen, kunne være en medvirkende årsak til at
kvinner sjeldnere får koronarsykdom premenopausalt. Det er imidlertid ikke mulig å si noe sikkert om
kausale sammenhenger på basis av dette tverrsnittsmaterialet.
INTRODUCTION
Phillips et al (1) first reported an inverse relationship
between the concentration of serum albumin (within a
narrow physiological range) and total mortality, and
mortality of cardiovascular diseases, cancer and other
diseases (1). Since there was no a priori hypothesis,
the observation was described as a ‘serendipitous’
finding. Subsequently, several reports on the apparent
protective influence of serum albumin against diseases
have appeared (2-7). Indeed, it has been suggested that
serum albumin concentration is "the best predictor of
mortality in elderly people" (3). The mechanisms be-
hind the apparent cardioprotective effect of albumin
remain to be elucidated. One hypothesis could be that
albumin protects against harmful lipid peroxidation
products, since albumin serves as an important extra-
cellular antioxidant (8).
It seemed, accordingly, of interest to examine
whether analysis of data in the Oslo Health Study
might be in support of a cardioprotective effect of
albumin. In addition, the lipid peroxidation estimate,
TBARS, was measured to examine whether variations
in lipid peroxidation might fit the hypothesis that albu-
min works through peroxidation protection.
MATERIAL AND METHODS
In 2000-2001 the Oslo Health Study was conducted
under the joint collaboration of the National Health
Screening Service of Norway (now the Norwegian
Institute of Public Health), the University of Oslo and
the Municipality of Oslo. The study population inclu-
ded all individuals in Oslo County born in 1970, 1960,
1955, 1940/41 and 1924/25. A total of 18,770 indivi-
duals (45.9% of the invited) participated – in other
words 8,404 men (42.4%) and 10,366 women (49.3%)
attended the physical examination and/or filled in at
least one of the questionnaires. For the five age cohorts
the participation rates were 36.1, 43.7, 46.5, 55.4 and
53.2%, respectively. Baseline measurements included
height, weight, waist and hip circumference, blood
pressure, heart rate, and non-fasting blood tests to
analyze serum total cholesterol, HDL-cholesterol, tri-
glycerides, and glucose.
One self-administered questionnaire was part of the
letter of invitation, whereas two supplementary ques-
tionnaires were handed out at the survey, and sent back
in pre-stamped self-addressed envelope. The question-
naires provided information on health status, symp-
toms, diseases and various aspects of health behaviour.108 A.T. HØSTMARK
Up to two reminders were sent to the non-respon-
ders of the invitation to participate in the survey. The
second reminder invited those living in the suburban
parts of the city to mobile screening units parked in the
neighbourhood of the invited. For further details, see:
http://www.fhi.no/tema/helseundersokelse/oslo/index.
html. The study protocol was placed before the Regio-
nal Committee for Medical Research Ethics and appro-
ved by the Norwegian Data Inspectorate. The study
has been conducted in full accordance with the World
Medical Association Declaration of Helsinki.
As a supplementary project of the study, the con-
centration of albumin was measured in sera from 6,333
subjects. Serum albumin was determined using the
bromcresol green method (9), with a reference interval
of 38-54 g/l. The intra- and inter-assay coefficients of
variation (CV) were 2% and 6% respectively. Since
albumin acts as an antioxidant (8), TBARS (Thiobarbi-
turic Acid Reactive Substances), which is a measure of
lipid peroxidation (10), was determined in 5,224 of the
available 'albumin sera'. The present results refer to
these sera. The intention was to have about equal
representation from each sex and from each of the
several age groups. It turned out, however, that there
was a greater representation of women than of men,
and also differences in the number of subjects in each
age group, with the highest number of subjects in age
group 40+45 years (Table 1). The sex distribution did
not vary much between the various age groups.
We previously observed that freezing and thawing
before TBARS determination did not have any major
influence on the results. Determination was carried out
according to Kosugi et al (11). Intra- and inter-assay
CV was 7 and 8%, respectively. The serum concentra-
tion of low density lipoprotein cholesterol (LDL) was
estimated by the Friedewald formula (12).
Statistical analyses were done using SPSS 11.1.
Albumin values were divided into low (≤47 g/l) and
high (>47 g/l) groups, or into tertiles. Using logistic
regression, odds ratio and 95% confidence intervals
were computed for the 'risk' of reporting myocardial
infarction, angina pectoris, or chest pain when walking
up stairs/hills ('yes' or 'no'), for low vs high serum
albumin, after adjusting for age, sex and smoking.
Linear regression was used to estimate association
between albumin, LDL and TBARS. ANOVA and
Scheffe test for multiple comparisons were performed
when evaluating significance of differences between
several mean values. A significance level of 0.05 was
used. SPSS 11.0 was used to produce the figures.
Table 1.  Number and distribution of subjects.
Men Women
Age (years) n Row% Col% n Row% Col%
30 423 39.4 21.0   651 60.6 20.3
40+45 689 38.5 34.2 1101 61.5 34.3
59-60 534 39.7 26.5   812 60.3 25.3
75-76 368 36.3 18.3   646 63.7 20.1
RESULTS
As shown in Figure 1 the serum albumin concentration
was fairly normally distributed in both sexes, but the
values were distributed towards slightly higher values
in men (47.9±3.0, mean±SD) than in women
(46.2±2.8). In men there was an age-related decrease
in the serum albumin concentration throughout all age
groups (Figure 2).
In contrast, for women the serum albumin concen-
tration remained constant in the two lowest age
groups, but decreased above age group 40+45 years.
For all age groups women had lower values than men.
It seems from the figure that the sex difference in
serum albumin concentration is reduced with
increasing age. By ANOVA a significant interaction
(p<0.001) between sex and age was found.
Figure 1.  Distribution of the serum albumin concentra-
tion in women (top; mean±SD: 46.2±2.8; n=3210), and
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Figure 2.  Mean serum albumin concentration in men
(dark grey bars, left) and women (lighter grey bars,
right), by age.
For each sex and age group the mean albumin
concentration in the self reported cases and 'controls'
was calculated (Figure 3 and 4). For both women and
men the mean albumin concentration was lower in
cases than in those without myocardial infarction. The
OR for reporting myocardial infarction was increased
in the low (≤47 g/l) vs high (>47 g/l) albumin group
(OR=1.95; 95% CI=1.30–2.93; p=0.001), when adjus-
ting for age (≥ 59 vs ≤ 45 years), sex and smoking.
Age was dichotomized due to an apparent non-linear
relationship between age and serum albumin concen-
tration. Also when considering subjects aged 59-60
years separately, low albumin increased the OR for
reporting MI (OR=2.26; 95%CI=1.06–4.79; p=0.034).
A similar finding was done for subjects aged 75-76
(OR=2.10; 95%CI=1.18–3.75); p=0.01).
To further examine the association between low
albumin and (self-reported) OR for coronary heart
diseases we studied albumin and odds ratio in subjects
reporting angina pectoris. Also for reporting this clini-
cal condition low albumin was a risk factor (OR=1.44;
95%CI=1.04–2.01; p=0.03), when adjusting for age,
sex and smoking.
Moreover, low albumin was associated with increa-
sed OR for reporting chest pain when walking up stairs
or hills (OR=1.36; 95% CI=1.12–1.64; p=0.002).
Results with TBARS
Some analyses were made to examine whether varia-
tions in lipid peroxidation might fit the hypothesis that
albumin exerts some of its effect via protection against
lipid peroxidation, as estimated by TBARS. There was
a positive correlation between age and TBARS (r=
0.101; p<0.001). Mean TBARS concentration in men
and women in the age groups is shown in Figure 5.
In age group 75-76 years the TBARS concentration
was significantly higher in men than in women
(p=0.004).
The observation that serum TBARS levels rose
with increasing age, as the albumin concentration fell,
would suggest that the two variables might be
inversely related. In men, but not in women, there was
a weak, but significant inverse relationship between
individual values of the two variables (r=–0.052;
p=0.01; n=2,014). Mean values of TBARS in tertiles
of albumin for men are shown in Figure 6. For each
tertile the mean TBARS concentration was signifi-
cantly (p<0.001) different from mean values in the two
other tertiles (oneway ANOVA, Scheffe multiple
comparison test). No association was found between
TBARS level and OR for reporting myocardial
infarction. There was, however, an association be-
tween low TBARS concentration and reduced OR for
reporting angina pectoris (OR=0.80; CI=0.692–0.934;
p=0.004). Additionally, for subjects above age 45
years, low TBARS was significantly (p=0.02) associa-
ted with reduced OR for reporting chest pain when
walking up stairs/hills, but the association was weak
(OR=0.86; 95% CI=0.74–0.99).
When examining separately the 134 subjects
reporting myocardial infarction there was a significant
(r=0.182; p=0.035) inverse relationship between serum
albumin and TBARS (Figure 7).
In contrast to this, in the 4,951 subjects answering
no to the question about myocardial infarction there
was no association between the two variables
(r=0.005; p=0.721).
Figure 3.    Mean serum albumin concentration in (self-
reported) MI cases (dark grey bars, left) and 'controls' (light-
er grey bars, right) by age, women. Number of cases/controls
in the 4 age groups: 2/632, 1/1073, 9/765, 33/595.110 A.T. HØSTMARK
LDL and TBARS
Lipid peroxidation, as estimated by TBARS, could be
related to the serum level of low density lipoproteins
(LDL). Including subjects (n=4,453) answering yes or
no to the question about myocardial infarction, with
positive LDL values within the physiological range,
i.e. ≤6 mmol/L (as estimated by the Friedewald formu-
la, see Methods), and excluding subjects reporting use
of cholesterol lowering drugs, there was a weak but
highly significant (r=0.086; p<0.001) positive linear
association between LDL and TBARS. This relation-
ship might, however, be spurious since both variables
increased with increasing age. Significance levels for
the linear relationship in each of the 4 age groups
were: p=0.41 (n=1,013), p=0.064 (n=1,624), p=0.005
(n=1,085), and p=0.192 (n=731). Thus, LDL was sign-
ificantly associated with TBARS only in age group 59-
60 years. There was no significant association between
serum triglycerides (and cholesterol) and TBARS.
Figure 4.    Mean serum albumin concentration in (self-
reported) MI cases (dark grey bars, left) and 'controls' (light-
er grey bars, right) by age, men. Number of cases/controls in
the 4 age groups: 0/417, 6/668, 33/488, 51/315.
Figure 5.  Age-related changes in TBARS (mean values
± SEM for men (upper curve) and women (lower curve).
Note that SPSS does not allow corresponding mean
values to be shown at the expected points on the abscissa;
curves are added to clarify groups.
Figure 6.  Serum TBARS in albumin tertiles, men.
Mean±SEM.
Figure 7.  Regression plot for serum albumin vs TBARS
in subjects reporting MI (n=134; r=0.182; p=0.035).SERUM ALBUMIN AND PREVALENCE OF CORONARY HEART DISEASE 111
DISCUSSION
The present results would seem to be in support of a
cardioprotective role for serum albumin, thus appa-
rently supporting the original work by Phillips et al
(1). It is emphasized, however, that the results are
obtained in a cross sectional study, implying that con-
clusions about causal relationships are not permitted.
In particular, it should be kept in mind that low serum
albumin values is a well known clinical feature accom-
panying various diseases. This raises the question
whether the lower albumin levels in MI cases than in
'controls' could have been caused by their disease.
Working against this suggestion is the observation that
the variation in serum albumin concentration was
within a narrow physiological range. In other words,
by considering only the albumin values of the MI
patients they would not be classified as patients. More
importantly, prospective epidemiological studies (and
experimental studies to explore mechanisms, vide
infra) provide supportive evidence in favour of a
cause-effect relationship between low levels of serum
albumin and cardiovascular diseases.
Questionnaire information about occurrence of dis-
eases could lead to erroneous conclusions. Among the
questions considered in the present work the question
about myocardial infarction probably is more reliable
than those about angina pectoris, and pain when wal-
king up stairs/hills. Noticeably, low serum albumin
concentration increased the 'risk' of reporting all three
atherosclerosis-related conditions.
In the population sample studied there was a higher
percentage of women than of men, but with a fairly
similar sex distribution in all age groups. Percentage of
subjects was highest in age group 40+45 years. This
distribution difference could make it difficult to gene-
ralize the observed quantitative relationship between
serum albumin concentration and self reported risk of
coronary heart disease. The purpose of the work was,
however, only to study associations.
The method for determination of serum albumin
has a high accuracy, as indicated by the low coeffici-
ents of variation. A high precision was ensured using
standard reference sera. Furthermore, we previously
observed no alteration in the albumin concentration
upon storage even for 3-6 years at –25 °C in the dark
(13).
The statistical analyses to evaluate associations
between serum albumin (and TBARS) and self repor-
ted coronary heart disease were robust since, in
general, similar observations were done in the whole
material, and in each sex separately, and also in more
than one age group.
In the study of Phillips et al (1) there was no a
priori albumin hypothesis. In the present work we have
considered whether the results would fit the hypothesis
that albumin might work through protection against
lipid peroxidation.
In general, albumin has an important role in regu-
lating the colloid osmotic pressure in blood, and serves
as a vehicle for the transport of many substances in
blood, such as hormones, drugs, amino acids and free
fatty acids (FFA). In addition, albumin acts also as an
important extracellular antioxidant (8). It would seem
reasonable to attribute the apparent protective role of
albumin to one or more of its several physiological
functions (8,14-16).
The role of albumin to bind and transport FFA, and
to protect against lipid peroxidation, seem of particular
interest. The various types of fatty acids serve as an
energy source for muscle contraction, and are also im-
portant building material for cell membranes. Additio-
nally, some fatty acids may influence several cell func-
tions, such as gene expression and intracellular signal
transduction. Some fatty acids are precursors of
eicosanoids (16).
The release of FFA from adipose tissue is enhan-
ced by physical activity due to increased adrenergic
stimulation, in order to ensure energy substrate for the
working muscle (14). The increased extraction of FFA
during  muscle activity prevents high and possibly
toxic levels of plasma FFA concentrations. However,
immediately post exercise there is a rapid increase in
the FFA concentration (18,19).
Fatty acids are released in high amounts during
various stress conditions without an accompanying
increased utilization, such as myocardial infarction,
serious burns, and preeclampsia (14,20-22). Increased
mortality is observed at serum FFA concentrations
above 1.2 mmol/l in myocardial infarction patients,
probably due to ventricular fibrillation caused by the
high FFA concentrations (20,21).
In geriatric patients we observed a positive
correlation between the serum FFA/albumin ratio and
some indicators of cell damage (23). A high
FFA/albumin ratio has toxic effects on red blood cells
in vitro, and can strongly inhibit the growth of liver,
kidney and endothelial cells in culture (24-28).
In vitro studies suggest that it is the easily per-
oxidized, polyunsaturated fatty acids which have the
strongest toxic potential. In this context it would seem
of interest that albumin is an important extracellular
antioxidant (8). One hypothesis to explain the ob-
served apparent protective function of high levels of
serum albumin against coronary heart diseases could
accordingly be that albumin binds free fatty acids so as
to prevent toxic FFA effects, and also formation of
oxidized low density lipoproteins (LDL).
Unfortunately, there are no data on serum fatty
acids and oxidized LDL in the present study. However,
it would appear that the present TBARS results are
relevant in this context, since this variable is a crude
measure of lipid peroxidation (10). The level of
TBARS should reflect overall FFA levels (free and
esterified, for example in LDL), provided similar
conditions otherwise. To study relationships with LDL
it seems appropriate to exclude subjects reporting
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there was a positive linear relationship between LDL
and TBARS. However, when studying each age group
separately, this relationship was significant only in
subjects aged 59-60 years, presumably indicating a
'loose coupling' between the variables.
The TBARS data could be interpreted in support of
the idea that lipid peroxidation is associated with coro-
nary risk. Also the results with self reported angina
pectoris, and chest pain during physical activity, would
be in line with an apparent cardioprotective role for
low serum concentration of TBARS, presumably due
to albumin protection. Again, conclusions about causal
relationships are not appropriate in a cross-sectional
questionnaire study.
Serum TBARS levels increased with increasing
age, as does the incidence of coronary heart diseases.
However, the variation in serum TBARS concentration
was large, probably reflecting considerable biological
variation and the unspecific nature of TBARS as a
measure of lipid peroxidation (10). It seems reasonable
to suppose considerable variation in the antioxidant
state of the subjects. Nevertheless, the finding that
TBARS increased with age could possibly be attribu-
ted to a reduced albumin protection of lipid peroxi-
dation. In men there was a significant inverse correla-
tion between individual TBARS and albumin values.
We previously observed a strong protective effect of
albumin against appearance of TBARS both in cell
cultures, and in a cell free system with free fatty acids
(25,28). Hypothetically, increased oxidative stress due
to lower albumin protection in higher age groups could
be a causative mechanism behind the age-related in-
creased occurrence of coronary heart disease. We have
no explanation for the lack of an inverse relationship
between albumin and TBARS in women.
Thus, it would appear that the well known age-
related increase in occurrence of myocardial infarction
is accompanied by a decrease in serum albumin levels.
It is therefore tempting to speculate that the age-related
increase in coronary heart disease could partly be
attributed to reduced albumin levels. In this regard it
would also seem of interest that an age-related reduc-
tion in serum albumin was not observed in women
when the age increased from the lowest age group (30
years) to the next (40+45 years). This raises the ques-
tion whether the apparent cardioprotective premeno-
pausal age period in women is related to their constant
albumin (and TBARS) level. After this age the serum
albumin concentration fell in both sexes.
Oxidation of LDL seems to be involved in the
development of atherosclerosis. Also a toxic effect of a
high FFA/albumin ratio on endothelial cells could
promote atherosclerosis and thrombosis. As observed
in vitro, albumin can strongly counteract the inhibitory
effect of fatty acids on growth of endothelial cells (28).
As pointed out above, conclusions about cause-
and-effect associations are not appropriate based upon
results of a cross sectional study. Self reported out-
come variables are unreliable. Also, a cross sectional
study implies differences other than age per se in the
various age groups. In spite of this, and with reference
to prospective epidemiological studies as well as many
experimental studies, it is tempting to suggest that the
present results of the Oslo Health Study would be in
support of a cardioprotective role of serum albumin.
Among several mechanisms of action it is hypothe-
sized that albumin may exert part of its effect through
protection against lipid peroxidation, but further evi-
dence is needed to substantiate this hypothesis.
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